1993
|
Sign up to set email alerts
Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma
Abstract: Patients with retinoblastoma, particularly bilateral retinoblastoma, should have careful follow-up, and interventions should be developed to reduce mortality from a second cancer.
Search citation statements
Order By: Relevance
Paper Sections
Select...
497
38
19
2
Citation Types
3
120
2
2
Year Published
Range
1993
19932026
2026Publication Types
Select...
430
104
14
2
Relationship
2
548
Authors
Journals
Cited by 550 publications
(127 citation statements)
References 0 publications
3
120
2
2
Order By: Relevance
Smart CitationsHow the paper below cites the one you are viewing
“…In apparent contrast to previous studies on associations between treatment of retinoblastoma and incidence of or mortality due to SPC, 10 , 11 , 12 , 15 , 16 , 19 , 20 , 21 , 22 , 35 our data did not show an increased overall risk in the patients with heritable retinoblastoma treated with external radiotherapy. However, we observed that a higher proportion of sarcomas was found inside the irradiated field in heritable retinoblastoma treated with external radiotherapy compared with no external radiotherapy.…”
Section: Discussion
contrasting
confidence: 99%
“…16 In addition, a German study reported an SIR of 179 for sarcoma among 648 patients with heritable retinoblastoma treated from 1940 to 2008, which is similar to the SIR of 181.1 found in our study. 21 In apparent contrast to previous studies on associations between treatment of retinoblastoma and incidence of or mortality due to SPC, [10][11][12]15,16,[19][20][21][22]35 our data did not show an increased overall risk in the patients with heritable retinoblastoma treated with external radiotherapy. However, we observed that a higher proportion of sarcomas was found inside the irradiated field in heritable retinoblastoma treated with external radiotherapy compared with no external radiotherapy.…”
Section: Discussion
contrasting
confidence: 99%
“…Consistent with previous studies, 10 , 11 , 14 , 20 , 22 we found that survivors of heritable retinoblastoma had a higher overall mortality rate than survivors of nonheritable retinoblastoma and that the increased mortality may be associated solely with SPC. We found a cumulative mortality rate for patients with heritable retinoblastoma of 48% at age 60 years, and 2 large studies have reported mortality rates for patients with heritable retinoblastoma of 21% at 40 years 20 and 75% at 70 years 22 after diagnosis.…”
Section: Discussion
supporting
confidence: 92%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…In apparent contrast to previous studies on associations between treatment of retinoblastoma and incidence of or mortality due to SPC, 10 , 11 , 12 , 15 , 16 , 19 , 20 , 21 , 22 , 35 our data did not show an increased overall risk in the patients with heritable retinoblastoma treated with external radiotherapy. However, we observed that a higher proportion of sarcomas was found inside the irradiated field in heritable retinoblastoma treated with external radiotherapy compared with no external radiotherapy.…”
Section: Discussion
contrasting
confidence: 99%
“…16 In addition, a German study reported an SIR of 179 for sarcoma among 648 patients with heritable retinoblastoma treated from 1940 to 2008, which is similar to the SIR of 181.1 found in our study. 21 In apparent contrast to previous studies on associations between treatment of retinoblastoma and incidence of or mortality due to SPC, [10][11][12]15,16,[19][20][21][22]35 our data did not show an increased overall risk in the patients with heritable retinoblastoma treated with external radiotherapy. However, we observed that a higher proportion of sarcomas was found inside the irradiated field in heritable retinoblastoma treated with external radiotherapy compared with no external radiotherapy.…”
Section: Discussion
contrasting
confidence: 99%
“…Consistent with previous studies, 10 , 11 , 14 , 20 , 22 we found that survivors of heritable retinoblastoma had a higher overall mortality rate than survivors of nonheritable retinoblastoma and that the increased mortality may be associated solely with SPC. We found a cumulative mortality rate for patients with heritable retinoblastoma of 48% at age 60 years, and 2 large studies have reported mortality rates for patients with heritable retinoblastoma of 21% at 40 years 20 and 75% at 70 years 22 after diagnosis.…”
Section: Discussion
supporting
confidence: 92%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…Our finding that somatic RB1 mutations were the second most common somatically acquired mutation in OA sebaceous carcinoma, occurring in 48% (14/29) of our patients, is consistent with the long-established propensity for patients with hereditary retinoblastoma to also develop OA sebaceous carcinoma (35)(36)(37)(38)(39)(40)(41). More strikingly, 93% (13/14) of the patients in our series who had RB1 mutation in their primary and/or locally recurrent OA sebaceous carcinoma also harbored TP53 mutations in the same tumor, and this coalescence of somatic mutations in TP53 and RB1 was enriched in older patients and in locally recurrent tumors, which not only supports a pivotal role for concomitant TP53 and RB1 abrogation in the development of OA sebaceous carcinoma, but also suggests that this molecular-genetic subtype confers a more locally aggressive clinical phenotype, possibly related to their higher nuclear grade features.…”
Section: Discussion
supporting
confidence: 90%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…Long‐term overall survival of patients with heritable retinoblastoma has improved over the last 70 years in Germany, and, in line with reports from other heritable retinoblastoma patient cohorts, second cancers were the most common cause of death . The incidence of second cancers in our cohort has remained essentially unchanged which may reflect the frequent use of radiotherapy even in recent decades.…”
Section: Discussion
supporting
confidence: 85%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…In apparent contrast to previous studies on associations between treatment of retinoblastoma and incidence of or mortality due to SPC, 10 , 11 , 12 , 15 , 16 , 19 , 20 , 21 , 22 , 35 our data did not show an increased overall risk in the patients with heritable retinoblastoma treated with external radiotherapy. However, we observed that a higher proportion of sarcomas was found inside the irradiated field in heritable retinoblastoma treated with external radiotherapy compared with no external radiotherapy.…”
Section: Discussion
contrasting
confidence: 99%
“…16 In addition, a German study reported an SIR of 179 for sarcoma among 648 patients with heritable retinoblastoma treated from 1940 to 2008, which is similar to the SIR of 181.1 found in our study. 21 In apparent contrast to previous studies on associations between treatment of retinoblastoma and incidence of or mortality due to SPC, [10][11][12]15,16,[19][20][21][22]35 our data did not show an increased overall risk in the patients with heritable retinoblastoma treated with external radiotherapy. However, we observed that a higher proportion of sarcomas was found inside the irradiated field in heritable retinoblastoma treated with external radiotherapy compared with no external radiotherapy.…”
Section: Discussion
contrasting
confidence: 99%
“…Consistent with previous studies, 10 , 11 , 14 , 20 , 22 we found that survivors of heritable retinoblastoma had a higher overall mortality rate than survivors of nonheritable retinoblastoma and that the increased mortality may be associated solely with SPC. We found a cumulative mortality rate for patients with heritable retinoblastoma of 48% at age 60 years, and 2 large studies have reported mortality rates for patients with heritable retinoblastoma of 21% at 40 years 20 and 75% at 70 years 22 after diagnosis.…”
Section: Discussion
supporting
confidence: 92%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…Our finding that somatic RB1 mutations were the second most common somatically acquired mutation in OA sebaceous carcinoma, occurring in 48% (14/29) of our patients, is consistent with the long-established propensity for patients with hereditary retinoblastoma to also develop OA sebaceous carcinoma (35)(36)(37)(38)(39)(40)(41). More strikingly, 93% (13/14) of the patients in our series who had RB1 mutation in their primary and/or locally recurrent OA sebaceous carcinoma also harbored TP53 mutations in the same tumor, and this coalescence of somatic mutations in TP53 and RB1 was enriched in older patients and in locally recurrent tumors, which not only supports a pivotal role for concomitant TP53 and RB1 abrogation in the development of OA sebaceous carcinoma, but also suggests that this molecular-genetic subtype confers a more locally aggressive clinical phenotype, possibly related to their higher nuclear grade features.…”
Section: Discussion
supporting
confidence: 90%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…Long‐term overall survival of patients with heritable retinoblastoma has improved over the last 70 years in Germany, and, in line with reports from other heritable retinoblastoma patient cohorts, second cancers were the most common cause of death . The incidence of second cancers in our cohort has remained essentially unchanged which may reflect the frequent use of radiotherapy even in recent decades.…”
Section: Discussion
supporting
confidence: 85%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…In apparent contrast to previous studies on associations between treatment of retinoblastoma and incidence of or mortality due to SPC, 10 , 11 , 12 , 15 , 16 , 19 , 20 , 21 , 22 , 35 our data did not show an increased overall risk in the patients with heritable retinoblastoma treated with external radiotherapy. However, we observed that a higher proportion of sarcomas was found inside the irradiated field in heritable retinoblastoma treated with external radiotherapy compared with no external radiotherapy.…”
Section: Discussion
contrasting
confidence: 99%
“…16 In addition, a German study reported an SIR of 179 for sarcoma among 648 patients with heritable retinoblastoma treated from 1940 to 2008, which is similar to the SIR of 181.1 found in our study. 21 In apparent contrast to previous studies on associations between treatment of retinoblastoma and incidence of or mortality due to SPC, [10][11][12]15,16,[19][20][21][22]35 our data did not show an increased overall risk in the patients with heritable retinoblastoma treated with external radiotherapy. However, we observed that a higher proportion of sarcomas was found inside the irradiated field in heritable retinoblastoma treated with external radiotherapy compared with no external radiotherapy.…”
Section: Discussion
contrasting
confidence: 99%
“…Consistent with previous studies, 10 , 11 , 14 , 20 , 22 we found that survivors of heritable retinoblastoma had a higher overall mortality rate than survivors of nonheritable retinoblastoma and that the increased mortality may be associated solely with SPC. We found a cumulative mortality rate for patients with heritable retinoblastoma of 48% at age 60 years, and 2 large studies have reported mortality rates for patients with heritable retinoblastoma of 21% at 40 years 20 and 75% at 70 years 22 after diagnosis.…”
Section: Discussion
supporting
confidence: 92%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…Our finding that somatic RB1 mutations were the second most common somatically acquired mutation in OA sebaceous carcinoma, occurring in 48% (14/29) of our patients, is consistent with the long-established propensity for patients with hereditary retinoblastoma to also develop OA sebaceous carcinoma (35)(36)(37)(38)(39)(40)(41). More strikingly, 93% (13/14) of the patients in our series who had RB1 mutation in their primary and/or locally recurrent OA sebaceous carcinoma also harbored TP53 mutations in the same tumor, and this coalescence of somatic mutations in TP53 and RB1 was enriched in older patients and in locally recurrent tumors, which not only supports a pivotal role for concomitant TP53 and RB1 abrogation in the development of OA sebaceous carcinoma, but also suggests that this molecular-genetic subtype confers a more locally aggressive clinical phenotype, possibly related to their higher nuclear grade features.…”
Section: Discussion
supporting
confidence: 90%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…Long‐term overall survival of patients with heritable retinoblastoma has improved over the last 70 years in Germany, and, in line with reports from other heritable retinoblastoma patient cohorts, second cancers were the most common cause of death . The incidence of second cancers in our cohort has remained essentially unchanged which may reflect the frequent use of radiotherapy even in recent decades.…”
Section: Discussion
supporting
confidence: 85%
Abstract